Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 256

Related Articles by Review for PubMed (Select 18422961)

1.

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.

J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.

PMID:
18422961
2.

Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.

Bertino G, Neri S, Bruno CM, Ardiri AM, Calvagno GS, Malaguarnera M, Toro A, Malaguarnera M, Clementi S, Bertino N, Di Carlo I.

Minerva Med. 2011 Oct;102(5):363-71. Review.

PMID:
22193346
3.

[Screening for hepatocellular carcinoma].

Leone N, Rizzetto M.

Minerva Med. 2005 Apr;96(2):95-108. Review. Italian.

PMID:
16172579
4.

Prognostic and diagnostic value of des-γ-carboxy prothrombin in liver cancer.

Bertino G, Ardiri AM, Calvagno GS, Bertino N, Boemi PM.

Drug News Perspect. 2010 Oct;23(8):498-508. doi: 10.1358/dnp.2010.23.8.1444236. Review.

PMID:
21031166
5.

Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.

Inagaki Y, Tang W, Makuuchi M, Hasegawa K, Sugawara Y, Kokudo N.

Liver Int. 2011 Jan;31(1):22-35. doi: 10.1111/j.1478-3231.2010.02348.x. Epub 2010 Sep 27. Review.

PMID:
20874725
6.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
7.

Serological markers of liver cancer.

Yuen MF, Lai CL.

Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):91-9. Review.

PMID:
15757806
8.

Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review.

Weitz IC, Liebman HA.

Hepatology. 1993 Oct;18(4):990-7. Review.

PMID:
8406374
9.

Hepatocellualar carcinoma serum markers.

Bertino G, Ardiri A, Malaguarnera M, Malaguarnera G, Bertino N, Calvagno GS.

Semin Oncol. 2012 Aug;39(4):410-33. doi: 10.1053/j.seminoncol.2012.05.001. Review.

PMID:
22846859
10.

New serum markers of hepatocellular carcinoma.

Masuzaki R, Karp SJ, Omata M.

Semin Oncol. 2012 Aug;39(4):434-9. doi: 10.1053/j.seminoncol.2012.05.009. Review.

PMID:
22846860
11.
12.

Serum markers of hepatocellular carcinoma.

Malaguarnera G, Giordano M, Paladina I, Berretta M, Cappellani A, Malaguarnera M.

Dig Dis Sci. 2010 Oct;55(10):2744-55. doi: 10.1007/s10620-010-1184-7. Epub 2010 Mar 26. Review.

PMID:
20339916
13.

Markers for hepatocellular carcinoma.

Wu AH, Sell S.

Immunol Ser. 1990;53:403-22. Review.

PMID:
1713067
14.

Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.

Yi X, Yu S, Bao Y.

Clin Chim Acta. 2013 Oct 21;425:212-20. doi: 10.1016/j.cca.2013.08.005. Epub 2013 Aug 13. Review.

PMID:
23954771
15.
16.

[Biological markers of hepatocellular carcinoma].

Arfaoui D, Elloumi H, Ajmi S.

Tunis Med. 2004 Apr;82(4):329-34. Review. French.

PMID:
15453027
17.

Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.

Daniele B, Bencivenga A, Megna AS, Tinessa V.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S108-12. Review.

PMID:
15508073
18.

Serum tumor markers for detection of hepatocellular carcinoma.

Zhou L, Liu J, Luo F.

World J Gastroenterol. 2006 Feb 28;12(8):1175-81. Review.

19.

Serum markers of hepatocellular carcinoma.

Spangenberg HC, Thimme R, Blum HE.

Semin Liver Dis. 2006 Nov;26(4):385-90. Review.

PMID:
17051452
20.

Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma.

Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K.

Oncology. 2002;62 Suppl 1:57-63. Review.

PMID:
11868787
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk